Trial on the Effect of Nabiximols Oromucosal Spray on Probe Midazolam

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  280711

• Contact name

  Samuel Israel

• Contact email

  samuel.israel@labcorp.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  2020-001334-34

• Clinicaltrials.gov Identifier

  20/NE/0128, REC Reference Number

• Duration of Study in the UK

  0 years, 2 months, 19 days

• Research summary

  Publication of this data is currently deferred.

• REC name

  North East - York Research Ethics Committee

• REC reference

  20/NE/0128

• Date of REC Opinion

  11 Jun 2020

• REC opinion

  Favourable Opinion